Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for NEVIF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
November 30, 2025 0.0481M
August 31, 2025 -0.0092M
May 31, 2025 0.0221M
February 28, 2025 -0.0163M
November 30, 2024 -0.0594M
August 31, 2024 0.061M
May 31, 2024 0.0355M
February 29, 2024 -0.1356M
November 30, 2023 -0.0819M
August 31, 2023 -0.1246M
May 31, 2023 -0.0234M
February 28, 2023 -0.0599M
November 30, 2022 -0.0192M
August 31, 2022 -0.0389M
May 31, 2022 -0.019M
February 28, 2022 -0.0374M
November 30, 2021 -0.0687M
August 31, 2021 -0.1252M
Date Value
May 31, 2021 -0.1571M
February 28, 2021 -0.1395M
November 30, 2020 -0.0829M
August 31, 2020 -0.1643M
May 31, 2020 -0.1304M
February 29, 2020 -0.2658M
November 30, 2019 -0.4069M
August 31, 2019 -0.5034M
May 31, 2019 -0.626M
February 28, 2019 -0.9153M
November 30, 2018 -0.4997M
August 31, 2018 -0.4747M
May 31, 2018 -0.4556M
February 28, 2018 -0.0792M
November 30, 2017 -0.2674M
August 31, 2017 -0.4208M
May 31, 2017 -0.2318M
February 28, 2017 -0.2394M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 0.728M
Integrated BioPharma, Inc. 0.517M
BioForce Nanosciences Holdings, Inc. -0.027M
Skinvisible, Inc. 0.0022M
Skinhealth Systems, Inc. 1.466M